Common heart drug could be new weapon against migraines
NCT ID NCT06248671
Summary
This study is testing whether atorvastatin, a medication typically used to lower cholesterol, can help prevent migraine attacks in adults with episodic migraine. Researchers want to confirm if results from smaller studies hold true in this larger trial with 450 participants. They'll compare two different doses (20mg and 40mg daily) against a placebo to see which works best and has the fewest side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EPISODIC MIGRAINE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Haukeland University Hospital
RECRUITINGBergen, Norway
Contact Email: •••••@•••••
-
Oslo University Hospital, Rikshospitalet
NOT_YET_RECRUITINGOslo, Norway
Contact Email: •••••@•••••
-
Oslo University Hospital, Ullevål
NOT_YET_RECRUITINGOslo, Norway
Contact Email: •••••@•••••
-
St. Olavs hospital
RECRUITINGTrondheim, 7022, Norway
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University Hospital Northern Norway
RECRUITINGTromsø, Norway
Contact Email: •••••@•••••
-
University Hospital, Akershus
NOT_YET_RECRUITINGLørenskog, Norway
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.